首页 > 按专业查询名词 > 查询PubMed相关文献
名词信息
Pubmed相关的文献
benign tumor of corpus uteri相关文献:
Literature review with PGI guidelines for delineation of clinical target volume for intact carcinoma cervix.
Bansal A, Patel FD, Rai B, Gulia A, Dhanireddy B, Sharma SC.
J Cancer Res Ther. 2013 Oct-Dec;9(4):574-82. doi: 10.4103/0973-1482.126450.
PMID:24518699
Cancer of the corpus uteri: 2021 update.
Koskas M, Amant F, Mirza MR, Creutzberg CL.
Int J Gynaecol Obstet. 2021 Oct;155 Suppl 1(Suppl 1):45-60. doi: 10.1002/ijgo.13866.
PMID:34669196
Significance of uterine corpus tumor invasion in early-stage cervical cancer.
Matsuo K, Machida H, Blake EA, Takiuchi T, Mikami M, Roman LD.
Eur J Surg Oncol. 2017 Apr;43(4):725-734. doi: 10.1016/j.ejso.2017.01.017. Epub 2017 Feb 3.
PMID:28215507
Corded and Hyalinized Endometrioid Adenocarcinoma (CHEC) of the Uterine Corpus are Characterized by CTNNB1 Mutations and Can Show Adverse Clinical Outcomes.
Ladwig NR, Umetsu SE, Zaloudek C, Rabban J, Garg K.
Int J Gynecol Pathol. 2021 Mar 1;40(2):103-115. doi: 10.1097/PGP.0000000000000671.
PMID:32909971
[Incidence and mortality of corpus uteri cancer in China, 2015].
Ma JY, Zhou Y, Lin YT, Xiang ZS, Zheng RS, Zhang SW, Wang SM, Chen R, Wei WW, He J.
Zhonghua Zhong Liu Za Zhi. 2021 Jan 23;43(1):108-112. doi: 10.3760/cma.j.cn112152-20200423-00373.
PMID:33472322
Global incidence and mortality trends of corpus uteri cancer and associations with gross domestic product, human development index, lifestyle, and metabolic risk factors.
Huang J, Chan WC, Ngai CH, Lok V, Zhang L, Lucero-Prisno DE 3rd, Xu W, Zheng ZJ, Elcarte E, Withers M, Wong MCS; NCD Global Health Research Group, Association of Pacific Rim Universities.
Int J Gynaecol Obstet. 2023 Sep;162(3):998-1009. doi: 10.1002/ijgo.14780. Epub 2023 May 2.
PMID:37128733
Luteal phase insufficiency.
Jones GS.
Clin Obstet Gynecol. 1973 Sep;16(3):255-73. doi: 10.1097/00003081-197309000-00016.
PMID:4590322
Human LY6 gene family: potential tumor-associated antigens and biomarkers of prognosis in uterine corpus endometrial carcinoma.
Rathbun LA, Magliocco AM, Bamezai AK.
Oncotarget. 2023 May 4;14:426-437. doi: 10.18632/oncotarget.28409.
PMID:37141412
Corpus Uteri Cancer in Kazakhstan: Recent Incidence Trends.
Azhetova Z, Khamidullina Z, Telmanova Z, Assylbek A, Bilyalova Z, Igissinova G, Orazova G, Kassenova D, Tarzhanova D, Kazbekova K, Idrissov K, Jakipbekova Z, Shuasheva Y, Dolanova G, Kuandykov Y, Mutagirov V, Kuandykov T, Igissinov N.
Asian Pac J Cancer Prev. 2023 Mar 1;24(3):849-857. doi: 10.31557/APJCP.2023.24.3.849.
PMID:36974537
Epidemiology of Breast, Corpus Uteri, and Ovarian Cancers in Lebanon With Emphasis on Breast Cancer Incidence Trends and Risk Factors Compared to Regional and Global Rates.
Lakkis NA, Abdallah RM, Musharrafieh UM, Issa HG, Osman MH.
Cancer Control. 2024 Jan-Dec;31:10732748241236266. doi: 10.1177/10732748241236266.
PMID:38419342
© Copyright 2021 鸿泰茂源  版权所有All Rights Reserved京ICP备11040441号-3